* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Charles River Laboratories International Buyback Yield % Chart
Charles River Laboratories International Annual Data
MIL:1CRL vs RVTY, QGEN, ICLR: Buyback Yield % Comparison
For the Diagnostics & Research subindustry, Charles River Laboratories International's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Charles River Laboratories International Buyback Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Charles River Laboratories International's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Charles River Laboratories International's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Charles River Laboratories International (MIL:1CRL) has a Buyback Yield % of 2.00 as of Jul. 09, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Charles River Laboratories International and its competitors. This is 545% above median its historical median of 0.31. Over the past decade, Charles River Laboratories International's Buyback Yield % has ranged from 0.10 to 6.26. According to the industry distribution chart, Charles River Laboratories International ranks #20 out of 91 companies in the Medical Diagnostics & Research industry, placing it in the top 22%.
Is Charles River Laboratories International's Buyback Yield % too high?
Charles River Laboratories International's current Buyback Yield % of 2.00 is 545% above median its 10-year median of 0.31. Over the past 10 years, this metric has ranged from a low of 0.10 to a high of 6.26. Based on the distribution chart, Charles River Laboratories International ranks #20 out of 91 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Charles River Laboratories International has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does Charles River Laboratories International's Buyback Yield % compare to RVTY and QGEN?
According to the Medical Diagnostics & Research industry distribution chart, Charles River Laboratories International ranks #20 out of 91 companies for Buyback Yield %. This places Charles River Laboratories International in the top 22% of its industry — outperforming the majority of peers. Historically, Charles River Laboratories International's own Buyback Yield % has ranged from 0.10 to 6.26 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Diagnostics & Research company?
A good Buyback Yield % depends on the Medical Diagnostics & Research industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Charles River Laboratories International and its competitors. Charles River Laboratories International's current Buyback Yield % is 2.00, which is 545% above median its own 10-year median of 0.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Charles River Laboratories International stock overvalued right now?
Charles River Laboratories International (MIL:1CRL) has a current Buyback Yield % of 2.00. The stock's GF Value™ is €124.86, compared to a current price of €143.90 — trading 15.2% above its estimated fair value. The current Buyback Yield % is 2.00, which is 545% above median its 10-year median of 0.31. Charles River Laboratories International's overall GF Score™ is 69/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Charles River Laboratories International (MIL:1CRL), the current Buyback Yield % is 2.00 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Charles River Laboratories International (MIL:1CRL) Overvalued in 2026?
Based on GuruFocus' analysis, Charles River Laboratories International stock appears to be overvalued.
The current stock price of €143.90 is trading 15.2% above its estimated GF Value™ of €124.86.
Key valuation signals for MIL:1CRL:
Buyback Yield %: 2.00 (545% above median its 10-year median of 0.31)
GF Value™: €124.86 vs. price of €143.90 (15.2% above fair value)
No single metric tells the full story. See the MIL:1CRL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Charles River Laboratories International Business Description
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
69GF Score
Get the complete analysis for MIL:1CRL
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:1CRL has been successfully added to your 
